search
Back to results

"Endoscopy First" or "Laparoscopic Cholecystectomy First" for Patients With Intermediate Risk of Choledocholithiasis

Primary Purpose

Choledocholithiasis

Status
Unknown status
Phase
Not Applicable
Locations
Lithuania
Study Type
Interventional
Intervention
endoscopic ultrasound
intraoperative cholangiography
ERCP
Ultrasound endoscope
Sponsored by
Vilnius University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Choledocholithiasis focused on measuring choledocholithiasis, endoscopic ultrasound, ERCP, intraoperative cholangiography, common bile duct stone, endoscopic retrograde cholangiopancreatography, gallstone disease, cholelithiasis, bile duct obstruction, laparoscopic cholecystectomy

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • patients with cholecystolithiasis when laparoscopic cholecystectomy is indicated
  • intermediate risk for choledocholithiasis (VUHI 2,6 - 6,9 and one of the predictors: dilated common bile duct, elevated total bilirubin or suspected stone in CBD on ultrasound)

Exclusion Criteria:

  • pregnancy;
  • acute cholangitis;
  • biliary pancreatitis;
  • acute cholecystitis, degree II-III by Tokyo guidelines 2013;
  • anastomosis in upper gastrointestinal tract;
  • other known cholestatic hepatopancreatobiliary disease;
  • known or suspected hepatitis of another origin (viral, toxic, etc.);
  • contraindications for general anaesthesia or surgery;
  • IV-VI class of American Society of Anesthesiologists physical status classification;
  • morbid obesity (body mass index > 40);
  • patient's refusal to participate in the study.

Sites / Locations

  • Vilnius University Hospital Santaros KlinikosRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Endoscopy first

Cholecystectomy first

Arm Description

Endoscopic ultrasound is used to evaluate bile ducts. If stones in extrahepatic bile ducts are seen ERCP and stone evacuation is performed during the same anaesthesia. Laparoscopic cholecystectomy is performed after endoscopic procedures in two days.

Laparoscopic cholecystectomy with intraoperative cholangiography is performed. If stones are found postoperative ERCP with stone evacuation is applied (during cholecystectomy if common bile duct is completely blocked or as soon as possible).

Outcomes

Primary Outcome Measures

Duration of treatment
duration from admission to hospital or decision to perform laparoscopic cholecystectomy to discharge in days

Secondary Outcome Measures

Accuracy of different management strategies
Proportion of correctly diagnosed (true positive and true negative) cases in all sample
Technical success of interventions (IOC, EUS, ERCP)
For intraoperative cholangiography: successful cannulation and contrast media injection into CBD. For endoscopic sonoscopy: successful visualisation of CBD. For ERCP: successful cannulation and contrast media injection into CBD.
Adverse events of interventions
Bleeding, acute pancreatitis, perforation, allergic reactions
Costs of treatment
charges of diagnostic procedures, invasive procedures, surgery, antibacterial treatment if needed and hospital charges

Full Information

First Posted
August 13, 2018
Last Updated
October 3, 2019
Sponsor
Vilnius University
search

1. Study Identification

Unique Protocol Identification Number
NCT03658863
Brief Title
"Endoscopy First" or "Laparoscopic Cholecystectomy First" for Patients With Intermediate Risk of Choledocholithiasis
Official Title
Comparison of Two Management Strategies, "Endoscopy First" and "Laparoscopic Cholecystectomy First", for Patients With Gallbladder Stones and Intermediate Risk for Choledocholithiasis
Study Type
Interventional

2. Study Status

Record Verification Date
October 2019
Overall Recruitment Status
Unknown status
Study Start Date
December 15, 2017 (Actual)
Primary Completion Date
December 15, 2020 (Anticipated)
Study Completion Date
December 15, 2020 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Vilnius University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The study compares two different methods to evaluate extrahepatic bile ducts for possible stones for patients with cholecystolithiasis and intermediate risk for choledocholithiasis when laparoscopic cholecystectomy is indicated. Endosonoscopic evaluation of bile ducts and endoscopic retrograde cholangiography (ERCP) on demand are performed before laparoscopic cholecystectomy for one arm. Intraoperative cholangiography during laparoscopic cholecystectomy and postoperative ERCP on demand are administered in another arm.
Detailed Description
Use of ERCP as a diagnostic tool should be minimized as it carries considerable risk (5 to 10%) of post-procedural complications. It is noticed that adverse events occur more often to patients with low risk of choledocholithiasis. Therefore the best possible patient selection for ERCP procedure is needed. At the Centre of Abdominal Surgery of Vilnius University Hospital Santaros klinikos an original prognostic index (Vilnius University Hospital index (VUHI)) is used for evaluation of risk of choledocholithiasis. It is calculated by formula VUHI = A/30 + 0.4×B, where A - total bilirubin concentration (µmol/l), B - common bile duct (CBD) diameter measured by ultrasound exam. A retrospective study evaluated its accuracy and determined threshold values for low, intermediate and high risk groups. The intermediate risk group (risk for choledocholithiasis 25-75%) would benefit from additional examination before ERCP. Endoscopic ultrasound (EUS) and intraoperative cholangiography are less invasive procedures with high accuracy identifying common bile duct stones. Main hypothesis of the trial is that intraoperative cholangiography with ERCP on demand can shorten the duration and costs of treatment and avoid diagnostic ERCPs.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Choledocholithiasis
Keywords
choledocholithiasis, endoscopic ultrasound, ERCP, intraoperative cholangiography, common bile duct stone, endoscopic retrograde cholangiopancreatography, gallstone disease, cholelithiasis, bile duct obstruction, laparoscopic cholecystectomy

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
106 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Endoscopy first
Arm Type
Active Comparator
Arm Description
Endoscopic ultrasound is used to evaluate bile ducts. If stones in extrahepatic bile ducts are seen ERCP and stone evacuation is performed during the same anaesthesia. Laparoscopic cholecystectomy is performed after endoscopic procedures in two days.
Arm Title
Cholecystectomy first
Arm Type
Active Comparator
Arm Description
Laparoscopic cholecystectomy with intraoperative cholangiography is performed. If stones are found postoperative ERCP with stone evacuation is applied (during cholecystectomy if common bile duct is completely blocked or as soon as possible).
Intervention Type
Procedure
Intervention Name(s)
endoscopic ultrasound
Intervention Description
Evaluation of bile ducts with endoscope with special ultrasonographic function
Intervention Type
Procedure
Intervention Name(s)
intraoperative cholangiography
Intervention Description
evaluation of bile ducts by injecting radiocontrast media to cystic duct during laparoscopic cholecystectomy
Intervention Type
Procedure
Intervention Name(s)
ERCP
Other Intervention Name(s)
endoscopic retrograde cholangiopancreatography
Intervention Description
evaluation of bile ducts by injecting radiocontrast media to common bile duct via endoscope inserted to duodenum
Intervention Type
Device
Intervention Name(s)
Ultrasound endoscope
Other Intervention Name(s)
Endosonoscope
Intervention Description
Endoscope with built-in ultrasound function
Primary Outcome Measure Information:
Title
Duration of treatment
Description
duration from admission to hospital or decision to perform laparoscopic cholecystectomy to discharge in days
Time Frame
up to one month
Secondary Outcome Measure Information:
Title
Accuracy of different management strategies
Description
Proportion of correctly diagnosed (true positive and true negative) cases in all sample
Time Frame
6 to 7 months
Title
Technical success of interventions (IOC, EUS, ERCP)
Description
For intraoperative cholangiography: successful cannulation and contrast media injection into CBD. For endoscopic sonoscopy: successful visualisation of CBD. For ERCP: successful cannulation and contrast media injection into CBD.
Time Frame
up to one month
Title
Adverse events of interventions
Description
Bleeding, acute pancreatitis, perforation, allergic reactions
Time Frame
up to one month
Title
Costs of treatment
Description
charges of diagnostic procedures, invasive procedures, surgery, antibacterial treatment if needed and hospital charges
Time Frame
up to one month

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: patients with cholecystolithiasis when laparoscopic cholecystectomy is indicated intermediate risk for choledocholithiasis (VUHI 2,6 - 6,9 and one of the predictors: dilated common bile duct, elevated total bilirubin or suspected stone in CBD on ultrasound) Exclusion Criteria: pregnancy; acute cholangitis; biliary pancreatitis; acute cholecystitis, degree II-III by Tokyo guidelines 2013; anastomosis in upper gastrointestinal tract; other known cholestatic hepatopancreatobiliary disease; known or suspected hepatitis of another origin (viral, toxic, etc.); contraindications for general anaesthesia or surgery; IV-VI class of American Society of Anesthesiologists physical status classification; morbid obesity (body mass index > 40); patient's refusal to participate in the study.
Facility Information:
Facility Name
Vilnius University Hospital Santaros Klinikos
City
Vilnius
Country
Lithuania
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Gintaras Simutis, MD, PhD
Phone
+370 5 236 5255
Email
gintaras.simutis@santa.lt
First Name & Middle Initial & Last Name & Degree
Ausra Aleknaite, MD
Phone
+370 618 18076
Email
ausra.aleknaite@santa.lt

12. IPD Sharing Statement

Plan to Share IPD
Undecided
Citations:
PubMed Identifier
33538700
Citation
Aleknaite A, Simutis G, Stanaitis J, Jucaitis T, Drungilas M, Valantinas J, Strupas K. Comparison of Endoscopy First and Laparoscopic Cholecystectomy First Strategies for Patients With Gallstone Disease and Intermediate Risk of Choledocholithiasis: Protocol for a Clinical Randomized Controlled Trial. JMIR Res Protoc. 2021 Feb 4;10(2):e18837. doi: 10.2196/18837.
Results Reference
derived

Learn more about this trial

"Endoscopy First" or "Laparoscopic Cholecystectomy First" for Patients With Intermediate Risk of Choledocholithiasis

We'll reach out to this number within 24 hrs